U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H21N3O3S
Molecular Weight 359.443
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXRABEPRAZOLE

SMILES

COCCCOC1=CC=NC(C[S@@+]([O-])C2=NC3=C(N2)C=CC=C3)=C1C

InChI

InChIKey=YREYEVIYCVEVJK-RUZDIDTESA-N
InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)/t25-/m1/s1

HIDE SMILES / InChI
Molecular Formula C18H21N3O3S
Molecular Weight 359.443
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
139594
Substance Class Chemical
Created
by admin
on Sat Dec 16 11:55:58 UTC 2023
Edited
by admin
on Sat Dec 16 11:55:58 UTC 2023
Record UNII
65JK8810RM
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXRABEPRAZOLE
WHO-DD  
Common Name English
RABEPRAZOLE, (R)-
Common Name English
R-(+)-RABEPRAZOLE
Common Name English
2-((R)-((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE
Systematic Name English
1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, (R)-
Systematic Name English
Dexrabeprazole [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC A02BC07
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
Code System Code Type Description
ChEMBL
CHEMBL1615209
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
FDA UNII
65JK8810RM
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
DRUG CENTRAL
4867
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
CAS
177795-60-7
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
DRUG BANK
DB13762
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
SMS_ID
100000176279
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
PUBCHEM
9906855
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
EPA CompTox
DTXSID00432680
Created by admin on Sat Dec 16 11:55:58 UTC 2023 , Edited by admin on Sat Dec 16 11:55:58 UTC 2023
PRIMARY
Related Record Type Details
POTASSIUM-TRANSPORTING ATPASE ALPHA CHAIN 1
TARGET -> INHIBITOR
Structure of DEXRABEPRAZOLE SODIUM
SALT/SOLVATE -> PARENT
Structure of RABEPRAZOLE, (S)-
ENANTIOMER -> ENANTIOMER
Structure of RABEPRAZOLE
RACEMATE -> ENANTIOMER
Related Record Type Details
Structure of 3-(3-METHOXYPROPOXY)-4-METHYL-5H-PYRIDO(1',2':4,5)(1,2,4)THIADIAZINO(2,3-A)BENZIMIDAZOL-13-IUM
METABOLITE ACTIVE -> PRODRUG
Related Record Type Details
Structure of 3-(3-METHOXYPROPOXY)-4-METHYL-5H-PYRIDO(1',2':4,5)(1,2,4)THIADIAZINO(2,3-A)BENZIMIDAZOL-13-IUM
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966